Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (107)	9/8/2006 9:48:31 PM
From: technetium	Respond to of 507

Thanks for the update.

To: Arthur Radley who wrote (107)	9/9/2006 12:42:08 AM
From: Robohogs	Read Replies (1) \| Respond to of 507

I am concerned here a small bit TD. 1. Not that big a deal as of yet that it has traded down as mkt overall has been week for BT and mkt is concerned about issues with launch. AMLN notably faked me out of it before doubling. If drug is launched no problem, this will recover. But that appears to be an IF where one should not be. 2. As discussed above, AGREED. 3. No opinion. I think stock has little downside and badness is priced in. Just my humble opinion. I only have a small position though so have not put money where mouth is. Jon